van Staa, T. P., Geusens, P. ., Bijlsma, J. W., Leufkens, H. G., & Cooper, C. . (2006). Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum. http://doi.org/10.1002/art.22117
J. Bijlsma
First name
J.
Middle name
W.
Last name
Bijlsma
Klop, C. ., Welsing, P. M., Cooper, C. ., Harvey, N. C., Elders, P. J., Bijlsma, J. W., … de Vries, F. . (2014). Mortality in British hip fracture patients, 2000-2010: a population-based retrospective cohort study. Bone. http://doi.org/10.1016/j.bone.2014.06.011
Klop, C. ., Gibson-Smith, D. ., Elders, P. J., Welsing, P. M., Leufkens, H. G., Harvey, N. C., … de Vries, F. . (2015). Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010. Osteoporos Int. http://doi.org/10.1007/s00198-015-3098-x
Klop, C. ., de Vries, F. ., Bijlsma, J. W., Leufkens, H. G., & Welsing, P. M. (2016). Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2015-208958